• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[骨髓移植:放射治疗的作用]

[Bone marrow transplantation: role of radiation therapy].

作者信息

Pape H

机构信息

Klinik für Strahlentherapie und Radiologische Onkologie, Universität Düsseldorf.

出版信息

Praxis (Bern 1994). 1996 Jun 4;85(23):749-52.

PMID:8693242
Abstract

Conditioning regimes before bone marrow transplantation serve a dual purpose. Firstly they have to destroy the host immune system sufficiently to allow permanent engraftment, secondly they have to eliminate the abnormal tumor cells. The special aim of total body irradiation is to eradicate those cells, which escape chemotherapy. The effectiveness of TBI is influenced by: delivered dose, fraction size and dose rate. Dose escalation improves the results of TBI. The seven year survival probability is 74%, if more than 9,9 Gy are administered and only 38% under 9,9 Gy. Combining TBI and chemotherapy promotes the outcome in patients with acute leukaemia and allogeneic bone marrow transplantation. The two year relapse rate is 16% with and 37% without TBI. Side effects are distinctly determined by fraction size and dose rate.

摘要

骨髓移植前的预处理方案有双重目的。首先,它们必须充分破坏宿主免疫系统以实现永久性植入,其次,它们必须消除异常肿瘤细胞。全身照射的特殊目的是根除那些逃避化疗的细胞。全身照射的有效性受以下因素影响:给予的剂量、分次剂量和剂量率。剂量递增可改善全身照射的效果。如果给予超过9.9戈瑞的剂量,七年生存率为74%,而低于9.9戈瑞时仅为38%。全身照射与化疗相结合可改善急性白血病患者和异基因骨髓移植患者的预后。有全身照射时两年复发率为16%,无全身照射时为37%。副作用明显由分次剂量和剂量率决定。

相似文献

1
[Bone marrow transplantation: role of radiation therapy].[骨髓移植:放射治疗的作用]
Praxis (Bern 1994). 1996 Jun 4;85(23):749-52.
2
Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.儿童急性白血病的异基因骨髓移植:采用分次全身照射、大剂量依托泊苷和环磷酰胺进行细胞减灭。
Bone Marrow Transplant. 2000 Mar;25(5):489-94. doi: 10.1038/sj.bmt.1702181.
3
Re-186 HEDP conditioning therapy in patients with advanced acute lymphoblastic leukemia before allogeneic bone marrow transplantation.186铼-羟基乙二膦酸盐预处理疗法用于晚期急性淋巴细胞白血病患者异基因骨髓移植前。
Clin Nucl Med. 2003 Sep;28(9):738-42. doi: 10.1097/01.rlu.0000082660.35154.55.
4
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan).
Bone Marrow Transplant. 1997 Nov;20(9):731-5. doi: 10.1038/sj.bmt.1700964.
5
[Whole body irradiation before bone marrow transplantation].[骨髓移植前的全身照射]
Acta Med Port. 1990 Nov-Dec;3(6):337-40.
6
Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.美法仑全身照射及自体骨髓移植治疗首次缓解后复发的成人急性白血病。
Bone Marrow Transplant. 1996 Jul;18(1):119-23.
7
Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.采用中剂量VP-16、环磷酰胺和全身照射预处理方案对成年急性淋巴细胞白血病患者进行异基因造血干细胞移植的良好疗效。
Biol Blood Marrow Transplant. 2008 May;14(5):568-75. doi: 10.1016/j.bbmt.2008.02.018.
8
Radiation protocols determine acute graft-versus-host disease incidence after allogeneic bone marrow transplantation in murine models.在小鼠模型中,辐射方案决定了异基因骨髓移植后急性移植物抗宿主病的发生率。
Int J Radiat Biol. 2007 Sep;83(9):625-36. doi: 10.1080/09553000701534572.
9
[Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].[113名处于第二次缓解期的儿童急性淋巴细胞白血病患者接受异基因骨髓移植与自体移植的对比研究。西班牙儿童骨髓移植协作组(GETMON)的研究结果]
Sangre (Barc). 1996 Apr;41(2):101-8.
10
[Bone marrow transplantation in the treatment of acute leukemias].[骨髓移植治疗急性白血病]
Ter Arkh. 1996;68(12):8-10.